Zhiming Li (Peng Sun)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Newly Diagnosed

Radiation Therapy

Ejection Fraction

Top Venues

Annals of hematology

American journal of hematology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Peng Sun, Hang Yang, Yu Wang, Baitian Zhao, Man Nie, Kangming Huang, Zhiming Li
Tislelizumab monotherapy in patients with previously untreated early-stage classical Hodgkin lymphoma: a real-world study. Annals of hematology (2023)
Zhiming Li, Hang Yang, Baitian Zhao, Yu Wang, Man Nie, Kangming Huang, Zhi-Ming Li
Outcomes of COVID-19 in patients with lymphomas participating in registered clinical trials: A real-world study from China in the Omicron outbreak era. Cancer medicine (2023)
Zhiming Li, Yajun Li, Cong Li, Kexing Ren, Yu Wang, Hang Yang, Wenqi Jiang, Liqun Zou, Haiyan Yang, Hui Zhou, Zhi-Ming Li
A Phase II Study of Sintilimab, Anlotinib, and Pegaspargase Sandwiched with Radiotherapy as First-line Therapy in Patients with Newly Diagnosed, Stage I-II Extranodal Natural-killer/T-cell Lymphoma. American journal of hematology (2023)